TEVA 2049 TEVA 2049 Pill - blue capsule/oblong
Pill with imprint TEVA 2049 TEVA 2049 is Blue, Capsule/Oblong and has been identified as Tolterodine Tartrate Extended-Release 4 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Tolterodine is used in the treatment of Urinary Incontinence; Urinary Frequency; Overactive Bladder and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 2049 TEVA 2049
Tolterodine Tartrate Extended-Release
- Imprint
- TEVA 2049 TEVA 2049
- Strength
- 4 mg
- Color
- Blue
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-2049 (Discontinued)
More about tolterodine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (75)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: urinary antispasmodics
- Breastfeeding
- En español
Patient resources
- Tolterodine drug information
- Tolterodine (Advanced Reading)
- Tolterodine Tablets
- Tolterodine Extended-Release Capsules
Other brands
Professional resources
- Tolterodine monograph
- Tolterodine Tartrate Capsules (FDA)
- Tolterodine Tartrate ER Tablets (FDA)
- Tolterodine Tartrate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
